The current valuation score of Beyondspring Inc is 8.36, ranking 151 out of 378 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.30, which is -71.13% below the recent high of -0.95 and -4887.28% above the recent low of -164.34.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.